Tenitramine

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Tenitramine
Accession Number
DB13637
Type
Small Molecule
Groups
Experimental
Description
Not Available
Structure
Thumb
Synonyms
Not Available
Categories
UNII
CKB16BAQ3S
CAS number
21946-79-2
Weight
Average: 416.3
Monoisotopic: 416.113920108
Chemical Formula
C10H20N6O12
InChI Key
DLDKCSIJFIPYRK-UHFFFAOYSA-N
InChI
InChI=1S/C10H20N6O12/c17-13(18)25-7-3-11(4-8-26-14(19)20)1-2-12(5-9-27-15(21)22)6-10-28-16(23)24/h1-10H2
IUPAC Name
2-[(2-{bis[2-(nitrooxy)ethyl]amino}ethyl)[2-(nitrooxy)ethyl]amino]ethyl nitrate
SMILES
[O-][N+](=O)OCCN(CCO[N+]([O-])=O)CCN(CCO[N+]([O-])=O)CCO[N+]([O-])=O

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AgmatineAgmatine may increase the vasodilatory activities of Tenitramine.
AmiodaroneAmiodarone may increase the vasodilatory activities of Tenitramine.
AmlodipineAmlodipine may increase the vasodilatory activities of Tenitramine.
AranidipineAranidipine may increase the vasodilatory activities of Tenitramine.
AvanafilThe risk or severity of hypotension can be increased when Avanafil is combined with Tenitramine.
AzelnidipineAzelnidipine may increase the vasodilatory activities of Tenitramine.
BarnidipineBarnidipine may increase the vasodilatory activities of Tenitramine.
BencyclaneBencyclane may increase the vasodilatory activities of Tenitramine.
BenidipineBenidipine may increase the vasodilatory activities of Tenitramine.
BepridilBepridil may increase the vasodilatory activities of Tenitramine.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
KEGG Compound
C17719
ChemSpider
146969
ChEBI
81292
ChEMBL
CHEMBL3707257
Wikipedia
Tenitramine
ATC Codes
C01DA38 — Tenitramine

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.444 mg/mLALOGPS
logP1.04ALOGPS
logP0.24ChemAxon
logS-3ALOGPS
pKa (Strongest Basic)7.6ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count14ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area215.96 Å2ChemAxon
Rotatable Bond Count19ChemAxon
Refractivity85.94 m3·mol-1ChemAxon
Polarizability36.46 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSNot Available
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as alkyl nitrates. These are organic compounds containing a nitrate that is O-linked to an alkyl group.
Kingdom
Organic compounds
Super Class
Organic oxygen compounds
Class
Organic oxoanionic compounds
Sub Class
Organic nitrates
Direct Parent
Alkyl nitrates
Alternative Parents
Trialkylamines / Organic nitro compounds / Organic nitric acids and derivatives / Organopnictogen compounds / Organooxygen compounds / Organic oxides / Hydrocarbon derivatives
Substituents
Alkyl nitrate / Organic nitro compound / Tertiary aliphatic amine / Tertiary amine / Organic nitric acid or derivatives / Organic 1,3-dipolar compound / Allyl-type 1,3-dipolar organic compound / Organic nitrogen compound / Organopnictogen compound / Organic oxide
Molecular Framework
Aliphatic acyclic compounds
External Descriptors
nitrates (CHEBI:81292)

Drug created on June 23, 2017 14:45 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates